Insiders · OMGA

OMGA insider transactions

Omega Therapeutics Inc. (OMGA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for OMGA

• 488d
  SEC Form 3 filed by new insider Varsalone Jeffrey T

  3 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 550d
  SEC Form 4 filed by Director Mehrotra Ravi

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 550d
  SEC Form 3 filed by new insider Mehrotra Ravi

  3 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 558d
  SEC Form 4 filed by Chief Scientific Officer Nelson Jennifer Ann

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 558d
  SEC Form 3 filed by new insider Nelson Jennifer Ann

  3 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 569d
  SEC Form 4 filed by Officer Certel Kaan

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 612d
  SEC Form 4 filed by Director Rosiello Robert L.

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 612d
  SEC Form 3 filed by new insider Rosiello Robert L.

  3 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 717d
  SEC Form 4 filed by Director Young Richard A

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 717d
  SEC Form 4 filed by Director Szela Mary T

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 717d
  SEC Form 4 filed by Director Schade Christian S

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 717d
  SEC Form 4 filed by Director Levy Elliott M.

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 717d
  SEC Form 4 filed by Director Werner Michelle C

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 717d
  SEC Form 4 filed by Director Mendlein John

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 717d
  SEC Form 4 filed by Director Boehm Rainer J.

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 717d
  SEC Form 4 filed by Director Kender Richard N

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 717d
  SEC Form 3 filed by new insider Kender Richard N

  3 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 738d
  SEC Form 4 filed by Certel Kaan

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 738d
  SEC Form 3 filed by new insider Certel Kaan

  3 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 738d
  New insider Chan Barbara Y claimed ownership of 37,683 shares (SEC Form 3)

  3 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 849d
  SEC Form 4 filed by Mccauley Thomas

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 849d
  SEC Form 4 filed by Schade Christian S (Amendment)

  4/A - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 849d
  SEC Form 4 filed by Karande Mahesh

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 849d
  SEC Form 4 filed by Moore Yan

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 849d
  SEC Form 4 filed by Reed Joshua

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 849d
  SEC Form 4 filed by Schade Christian S

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 849d
  SEC Form 4 filed by Zeng Ling

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1014d
  SEC Form 4 filed by Werner Michelle C

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1014d
  SEC Form 3 filed by new insider Werner Michelle C

  3 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1062d
  SEC Form 4 filed by Schade Christian S

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1062d
  SEC Form 3 filed by new insider Schade Christian S

  3 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1095d
  SEC Form 4 filed by Boehm Rainer J.

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1095d
  SEC Form 4 filed by Mendlein John

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1095d
  SEC Form 4 filed by Afeyan Noubar

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1095d
  SEC Form 4 filed by Beshar Luke M

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1095d
  SEC Form 4 filed by Young Richard A

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1095d
  SEC Form 4 filed by Szela Mary T

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1095d
  SEC Form 4 filed by Levy Elliott M.

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1099d
  SEC Form 4 filed by Young Richard A

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1132d
  SEC Form 4 filed by Young Richard A

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1155d
  SEC Form 4 filed by Young Richard A

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1176d
  SEC Form 4 filed by Omega Therapeutics Inc.

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1194d
  SEC Form 4 filed by Karande Mahesh

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1194d
  SEC Form 4 filed by Moore Yan

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1194d
  SEC Form 4 filed by Mcmanus Kevin

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1194d
  SEC Form 4 filed by Zeng Ling

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1194d
  SEC Form 4 filed by Reed Joshua

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1194d
  SEC Form 4 filed by Mccauley Thomas

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1196d
  SEC Form 4: Flagship Pioneering Inc. bought $19,208,732 worth of shares (3,323,310 units at $5.78)

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1196d
  SEC Form 3: New insider Flagship Pioneering Fund Vii General Partner Llc claimed ownership of 1,329,324 shares

  3 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1244d
  SEC Form 4: Young Richard A sold $160,000 worth of shares (20,000 units at $8.00) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 764,118 units

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1318d
  SEC Form 4 filed by Karande Mahesh

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1318d
  SEC Form 4 filed by Mccauley Thomas

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1318d
  SEC Form 4 filed by Zeng Ling

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1318d
  SEC Form 4 filed by Mcmanus Kevin

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1318d
  SEC Form 4 filed by Moore Yan

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1318d
  SEC Form 4 filed by Reed Joshua

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1362d
  SEC Form 4: Young Richard A sold $80,000 worth of shares (10,000 units at $8.00) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 784,118 units

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1376d
  SEC Form 4 filed by Boehm Rainer J.

  4 - Omega Therapeutics, Inc. (0001850838) (Issuer)
• 1376d
  SEC Form 3 filed by new insider Boehm Rainer J.

  3 - Omega Therapeutics, Inc. (0001850838) (Issuer)